Gilead Sciences (NASDAQ: GILD) insider plans $3.9M share sale

Gilead Sciences insider Johanna Mercier has filed a Form 144 indicating her intent to sell up to 28,000 shares of common stock, valued at approximately $3.85 million. These shares are primarily linked to a stock option exercise and performance shares, with previous sales by Mercier in June and July 2026 also disclosed. The filing, processed through Morgan Stanley Smith Barney LLC, reflects standard insider transaction procedures.